Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2012
02/16/2012CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
02/16/2012CA2807634A1 Inhibitors of bruton's tyrosine kinase
02/16/2012CA2806646A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
02/16/2012CA2806547A1 Heterocyclic antiviral compounds
02/15/2012EP2418209A1 Aurora kinase modulators and method of use
02/15/2012EP2418206A2 Benzodiazepine derivatives useful in the treatment of autoimmune disorders
02/15/2012EP2418205A1 Pyrimidine urea derivatives as kinase inhibitors
02/15/2012EP2418203A1 Cyclic compound having substituted phenyl group
02/15/2012EP2418202A1 New compounds
02/15/2012EP2418196A1 Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors
02/15/2012EP2417127A1 Kinase inhibitors and method of treating cancer with same
02/15/2012EP2417125A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
02/15/2012EP2417124A2 Serotonin and norepinephrine reuptake inhibitor
02/15/2012EP2417123A2 Therapeutic compositions and related methods of use
02/15/2012EP2417122A1 Indole derivatives and methods for antiviral treatment
02/15/2012EP2417121A1 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
02/15/2012EP2417120A1 Substituted piperidines as ccr3 antagonists
02/15/2012EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
02/15/2012EP2417108A1 Organic compounds and their uses
02/15/2012EP2321286B1 Substituted n-oxide pyrazine derivatives
02/15/2012EP2027107B1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
02/15/2012EP1831199B1 MMP inhibitors
02/15/2012EP1771441B8 Novel carboxamides for use as xa inhibitors
02/15/2012CN102356076A Compound having benzotriazole ring structure and organic electroluminescent element
02/15/2012CN102356075A Compositions and methods for inhibition of the jak pathway
02/15/2012CN102356074A Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
02/15/2012CN102356068A 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
02/15/2012CN102356065A Piperidine derivatives as nk3 receptor antagonists
02/15/2012CN102351941A Method for labeling functional molecules with <18>F
02/15/2012CN102351907A Method for synthesizing metal N-heterocyclic carbene complex
02/15/2012CN102351847A Industrial method for refining esomeprazole sodium salt
02/15/2012CN102351846A Novel omeprazole sodium compound and medicinal composition thereof
02/15/2012CN102351845A Method for selectively preparing S-(-)-omeprazole by using high enantiomer
02/15/2012CN102351844A Pantoprazole sodium compound and pharmaceutical composition thereof
02/15/2012CN102351843A Synthesis method of 2-methyl piperazine lomefloxacin
02/15/2012CN102351842A F,G,H,I and K crystal forms of imatinib mesylate
02/15/2012CN101863839B N-3-芳酰胺-5-环丙烷螺环乙内酰脲衍生物及其制备方法和应用 N-3- aramid -5- cyclopropane spiro hydantoin derivatives, preparation method and application
02/15/2012CN101298435B 邻甲酰氨基苯甲酰胺类化合物及其应用 O Formylamino benzamide compounds and their application
02/15/2012CN101006074B 作为nk1拮抗剂的哌啶衍生物 As nk1 antagonists piperidine derivative
02/14/2012US8115006 Process for producing anthranilamide compound
02/14/2012US8115005 Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
02/14/2012US8114999 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
02/14/2012US8114991 Used for the control of a range of harmful weeds
02/14/2012US8114989 Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors
02/14/2012US8114901 Crystalline 2,5-dione-3-(1-methyl-1H-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl]-1H-pyrrole mono-hydrochloride
02/14/2012US8114899 2H- or 3H-benzo[e]indazol-1-yl carbamate derivatives, the preparation and therapeutic use thereof
02/14/2012US8114894 Bicyclic compounds and methods of making and using same
02/14/2012US8114891 4-substituted quinuclidine derivatives, methods of production, pharmaceutical uses thereof
02/14/2012US8114884 CXCR4 antagonists for the treatment of medical disorders
02/14/2012US8114882 Antitumor agents; kinase inhibitors; angiogenesis inhibitors; arteriosclerosis ; antiinflammatory agents
02/14/2012US8114880 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid MTP inhibiting compounds
02/14/2012US8114879 Piperazine derivatives useful as CCR5 antagonists
02/14/2012US8114871 3-amido-pyrrolo[3,4-C]pyrazole-5(1H,4H,6H) carbaldehyde derivatives
02/14/2012US8114865 Indazole derivatives as kinase inhibitors for the treatment of cancer
02/14/2012US8114435 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
02/14/2012CA2536429C 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/09/2012WO2012019003A1 Substituted indole and azaindole oxoacetyl piperazinamide derivatives
02/09/2012WO2012018105A1 Crystal of anti-bacterial compound
02/09/2012WO2012018059A1 Heterocyclic compound
02/09/2012WO2012018058A1 Fused heterocyclic ring compound
02/09/2012WO2012017239A2 Chemical compounds
02/09/2012WO2012017166A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/09/2012WO2012016993A1 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
02/09/2012WO2012016510A1 Pyridazine derivatives and use thereof as medicaments for treating microrna viral infection
02/09/2012WO2011156921A3 Catalyst ligands, catalytic ligand complexes and polymerization processes using same
02/09/2012WO2011156900A3 Compounds, compositions and methods for treatment of multiple sclerosis
02/09/2012US20120035408 Compounds useful as inhibitors of atr kinase
02/09/2012US20120035407 Compounds useful as inhibitors of atr kinase
02/09/2012US20120035368 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES
02/09/2012US20120035363 Crystalline 4-(3-chloro-2-fluoroanilino)-7 methoxy-6-...
02/09/2012US20120035351 Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors
02/09/2012US20120035239 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
02/09/2012US20120035222 Solid forms of 2-Chloro-4-[1-(4-fluoro-phenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]-pyridine
02/09/2012US20120035217 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors
02/09/2012US20120035214 Renin inhibitors
02/09/2012US20120035211 Novel polymorphs of saquinavir
02/09/2012US20120035194 Substituted 2-amino-fused heterocyclic compounds
02/09/2012US20120035187 Anti-neurodegenerative disease agent
02/09/2012US20120035168 N-((6-amino-pyridin-3-yl)methyl)-heteroaryl-carboxamides
02/09/2012US20120035164 Chemical compounds
02/09/2012US20120035159 Substituted isoquinoline derivative
02/09/2012US20120035157 2-pyridone derivatives as neutrophil elastase inhibitors and their use
02/09/2012US20120035155 Indole-2-carboxamide deivative
02/09/2012US20120035154 Modulators of Cellular Adhesion
02/09/2012US20120035150 Mif inhibitors and their uses
02/09/2012US20120035134 Chemical compounds
02/09/2012US20120035131 Pyrazoline compounds
02/09/2012US20120034678 Diaryl Ethers
02/09/2012US20120034161 Pretargeting kit, method and agents used therein
02/09/2012US20120032158 Charge transport compositions and electronic devices made with such compositions
02/09/2012US20120031422 Fluorescent entity, dyeing composition containing at least one fluorescent entity comprising at least one heterocycle, with at least one internal cationic charge, and method for lightening keratin materials using said at least one fluorescent entity
02/09/2012CA2807093A1 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
02/09/2012CA2805827A1 Chemical compounds
02/09/2012CA2805440A1 Substituted biphenylene compounds and methods of use thereof for the treatment of viral diseases
02/09/2012CA2805206A1 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf
02/08/2012EP2415769A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
02/08/2012EP2415765A1 Pyrimidine compound
02/08/2012EP2415764A1 Prophylactic and/or therapeutic agent for anemia comprising tetrahydroquinoline compound as active ingredient
02/08/2012EP2415763A1 Pharmaceutical composition for treating or preventing glaucoma